Founder Adds Shares as Price Looks for Support: Kinder Morgan Inc Stock (NYSE: KMI)

shutterstock_1196642290 1 300x200

Kinder Morgan Inc (NYSE: KMI) was founded in February 1997 by Richard Kinder and William Morgan. It began with the acquisition Enron Liquids Pipeline, a publicly traded limited partnership. The company today attracts dividend investors with its 7.75% yield and the deal just sweetened with the additional acquisition by Richard Kinder.

  • Special: 32,481% Growth: The SmartPhone Startup Outpacing Apple and Samsung
  • In 2014, the company shook the master limited partnership (MLP) world when it brought all of their majority owned MLPs under one corporate structure. The company that had pioneered the MLP industry had now abandoned the structure because of the limited opportunities to invest in pipeline infrastructure. The company chose a path to use debt to fund investment.

    On July 28, Richard Kinder added 300,000 shares of KMI at $14.14. For the executive chairman and 10% owner, the $4.2 million addition was a relatively small addition to his holdings. However, the timing of his purchases over the last year have been pretty good.

    • Bill O'Reilly Interviews Wall Street Expert to Help YOU Achieve the American Dream

      "We're going to bring back the American Dream... bigger, better, bolder, richer, safer, and stronger than ever before." - President Donald Trump

      During Trump's first term, 8 million Americans became millionaires despite constant resistance from Democrats and even some Republicans in his cabinet.

      Now, with Republicans controlling both houses and the Fed cutting rates, everything is aligned for even greater growth.

      Bill O'Reilly interviews investment expert Alexander Green who reveals details on 6 stocks with the potential to soar under Trump's pro-business policies.

      Get the Details Right Here

    Here are links to our latest insider trading reports.

    Chinese Energy Technology Company Gets Recharged by Insiders: CBAK Energy Technology Inc Stock (NASDAQ: CBAT)

  • Special: The Crypto that Could Replace Visa?
  • Pandemic Selling at Its Finest: Regeneron Pharmaceuticals Inc Stock (NASDAQ: REGN)
    Action to Take: As the price is testing its support near $14, this is an interesting point to look at acquiring shares given the company has already announced its quarterly earnings on July 22.

    Those looking to acquire the company at a lower price and increase the yield may want to consider selling a put. The 18 SEP 20 $13 put can be sold for around $0.31.

    [wp-post-author image-layout="round"]